Stock Events

Stock Events

Corbus Pharmaceuticals (3371.F) Q4 2024 Earnings

7NovConfirmed

Q4 2023

Q2 2024

Q3 2024

Q4 2024

-1.97

-1.57

-1.17

-0.77

Details

Expected EPS

-0.8813127939700001

Actual EPS

-1.0646814999999998

Surprise EPS

-0.18

Surprise Percent

+20.81%

Description

Corbus Pharmaceuticals (3371.F) has reported earnings of -1.0646814999999998 per share for Q4 2024.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.